自体干细胞移植后,造血干细胞的克隆进化
Hidetaka Uryu1, Koichi Saeki2, Hiroshi Haeno2
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nature genetics
|July 2, 2025
概括
癌症化疗,特别是梅尔法兰,损害了造血干细胞和原生细胞 (HSPC) 的基因组完整性. 这种损伤加速了克隆老化,模仿了自然的老化过程,并可能导致髓状瘤.
科学领域:
- 血液学 血液学 血液学
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- 癌症化疗对基因组完整性和正常血液形成的克隆动态的影响仍然不太清楚.
- 化学疗法等外源性压力因素可能会影响长期的造血健康.
研究的目的:
- 研究化疗对血造干细胞和原生细胞 (HSPCs) 基因组景观和克隆进化的影响.
- 为了确定化疗是否加快了造血系统的衰老.
主要方法:
- 从化疗治疗的多发性骨髓瘤患者和健康捐赠者的1276个单细胞衍生HSPC殖民地进行全基因组测序.
- 对突变特征和克隆架构的分析.
- 对与治疗相关的骨髓瘤样本的综合遗传学分析.
主要成果:
- 梅尔法兰治疗显著增加了HSPCs的突变负担,创造了一个独特的突变特征.
- 其他化疗剂对HSPC突变的影响很小.
- 化疗后HSPC的克隆多样性和结构类似于老年人的克隆多样性和结构,这表明克隆衰老加速.
- 观察到橄克隆性血液形成的进展,这表明化疗加快了这种衰老的表型.
结论:
- 化疗,特别是梅尔法兰,诱导HSPCs显著的基因组变化,加速克隆老化.
- 这些发现支持一种模式,即化疗诱导的HSPC变化可以导致原克隆转变为单克隆转变,可能导致与治疗相关的髓状瘤.
- 进一步的研究对于了解癌症化疗的长期血液学后果至关重要.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Bone Marrow Sampling and Transplants
506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K


